Advanced Clinical Skill Course Program
Refine your expertise through advanced, case-based clinical training. Gain hands-on experience in complex procedures guided by SMC’s leading specialists.
Deepen Your Insight into MDS and AML
Samsung Medical Center launches three day course of the Advanced Course on Myelodysplastic Syndromes and Acute Myeloid Leukemia program. The program covers myelodysplastic syndrome and acute myelogenous leukemia through education and scientific lectures by discussing diagnosis of disease, standard therapies, and the latest developments in genomics and transplantation. This interactive and conductive format of program extends your clinical knowledge in these fields.
Training Faculty
Associated Physicians
Hee-Jin Kim
Professor, Department of Laboratory Medicine & Genetics, Sungkyunkwan University School of Medicine
Diagnostic Hematology, Genetic Counseling, Coagulation Genetics, Hematology Genetics
Duck Cho
Professor, Department of Laboratory Medicine, Sungkyunkwan University School of Medicine
Cell Therapy, Flow Cytometry, Transfusion Medicine
Chul Won Jung
Professor, Department of Hematology & Oncology, Samsung Medical Center, Sungkyunkwan University
Bleeding Disorders, Anemia, Chronic Myeloproliferative Disorders, Hematopoietic Stem Cell Transplantation, Leukemia
What to Learn
-
01
Diagnosis of Myelodysplastic Syndrome (MDS)
-
02
Clinical Flow cytometry
-
03
Next-Generation Sequencing (NGS) in Myelodysplastic Syndromes and Myeloid malignancies
-
04
Treatment of AML
-
05
Hematopoietic cell transplantation of MDS and AML
-
06
Treatment of Lower-risk of MDS
-
07
Treatment of Higher-risk of MDS
-
08
Case presentation and discussion
-
09
Clinical Trials of MDS and AML
Program Details
Registration fee
USD 1,800/participant (Includes tuition, accommodation, meals, and program book)
Required Documents
- All required documents must be originals in English or notarized translations into English.
- Please submit all documents as a single PDF file (File name: SITAT_First name_Last name_Country)
- Incomplete applications will not be considered.

